-
The Stephenson Cancer Center in Oklahoma City received a National Cancer Institute designation Wednesday, which will help provide more assistance for…
-
The U.S. Preventive Services Task Force proposes each man decide with his doctor whether to undergo routine PSA testing, citing recent evidence of benefits and ways to minimize downsides of screening.
-
Cancer patients increasingly delay or skip taking medication because they can't afford it. New drugs that can cost $100,000 or more a year mean more people suffering "financial toxicity."
-
Scientists hunting cures for cancer hope to find therapies with fewer side effects. But there's also new evidence that old-style chemotherapy sometimes helps gentler treatments work better.
-
Scanning people at risk for lung cancer finds many nodules that aren't cancerous but prompt more procedures, a study at the VA finds. A small number of people did get their cancer diagnosed early on.
-
Patients switching to generic medicines and hard bargaining with drugmakers helped moderate spending on prescription drugs in 2015, according to Express Scripts, a manager of drug benefits.
-
While genetic mutations are nearly ubiquitous in cancer, they may not always be the driving force for disease, some researchers say. They suggest looking at disruptions in cellular metabolism.
-
Most breast cancer cases are in women, so treatment and support are geared toward them. Men with breast cancer can feel isolated. One man was given a pink ice pack.
-
A new study renews questions about how aggressively doctors should treat a very early form of breast cancer or pre-cancer.
-
A British hospital will soon launch a clinical trial using dogs to detect prostate cancer. With their powerful noses, the dogs can sniff out cancer in as little as one-fifth of a teaspoon of urine.